{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:25:39Z","timestamp":1790807139256,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T00:00:00Z","timestamp":1546473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T00:00:00Z","timestamp":1546473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["NIHR21AR067473"],"award-info":[{"award-number":["NIHR21AR067473"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00774-018-0982-4","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T10:40:49Z","timestamp":1546512049000},"page":"773-779","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pigment epithelium-derived factor (PEDF) reduced expression and synthesis of SOST\/sclerostin in bone explant cultures: implication of PEDF-osteocyte gene regulation in vivo"],"prefix":"10.1007","volume":"37","author":[{"given":"Feng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarrett D.","family":"Cain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Tombran-Tink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Niyibizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,3]]},"reference":[{"key":"982_CR1","first-page":"1651","volume":"24","author":"F Li","year":"2015","unstructured":"Li F, Song N, Tombran-Tink J, Niyibizi C (2015) Pigment epithelium derived factor suppresses expression of Sost\/sclerostin by osteocytes: implication for its role in bone matrix mineralization. J Cell Physiol 24:1651\u20131661","journal-title":"J Cell Physiol"},{"key":"982_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1126\/science.285.5425.245","volume":"285","author":"DW Dawson","year":"1999","unstructured":"Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP (1999) Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285:245\u2013248","journal-title":"Science"},{"key":"982_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0014-4835(91)90248-D","volume":"53","author":"J Tombran-Tink","year":"1991","unstructured":"Tombran-Tink J, Chader GG, Johnson LV (1991) PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 53:411\u2013414","journal-title":"Exp Eye Res"},{"key":"982_CR4","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1073\/pnas.90.4.1526","volume":"90","author":"FR Steele","year":"1993","unstructured":"Steele FR, Chader GJ, Johnson LV, Tombran-Tink J (1993) Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci U S A. 90:1526\u20131530","journal-title":"Proc Natl Acad Sci U S A."},{"key":"982_CR5","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.2353\/ajpath.2010.091085","volume":"177","author":"TC Ho","year":"2010","unstructured":"Ho TC, Chen SL, Shih SC, Wu JY, Han WH, Cheng HC, Yang SL, Tsao YP (2010) Pigment epithelium-derived factor is an intrinsic antifibrosis factor targeting hepatic stellate cells. Am J Pathol 177:1798\u20131811","journal-title":"Am J Pathol"},{"key":"982_CR6","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1074\/jbc.M507401200","volume":"281","author":"J Cai","year":"2006","unstructured":"Cai J, Jiang WG, Grant MB, Boulton M (2006) Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J Biol Chem 281:3604\u20133613","journal-title":"J Biol Chem"},{"key":"982_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2174\/156652410791065336","volume":"10","author":"J Tombran-Tink","year":"2010","unstructured":"Tombran-Tink J (2010) PEDF in angiogenic eye diseases. Curr Mol Med 10:267\u2013278","journal-title":"Curr Mol Med"},{"key":"982_CR8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ajhg.2011.01.015","volume":"88","author":"J Becker","year":"2011","unstructured":"Becker J, Semler O, Gilissen C, Li Y, Bolz HJ, Giunta C, Bergmann C, Rohrbach M, Koerber F, Zimmermann K, de Vries P, Wirth B, Schoenau E, Wollnik B, Veltman JA, Hoischen A, Netzer C (2011) Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 88:362\u2013371","journal-title":"Am J Hum Genet"},{"key":"982_CR9","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1002\/jbmr.487","volume":"26","author":"EP Homan","year":"2011","unstructured":"Homan EP, Rauch F, Grafe I, Lietman C, Doll JA, Dawson B, Bertin T, Napierala D, Morello R, Gibbs R, White L, Miki R, Cohn DH, Crawford S, Travers R, Glorieux FH, Lee B (2011) Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J Bone Miner Res 26:2798\u20132803","journal-title":"J Bone Miner Res"},{"key":"982_CR10","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/jbmr.1480","volume":"27","author":"G Venturi","year":"2012","unstructured":"Venturi G, Gandini A, Monti E, Dalle Carbonare L, Corradi M, Vincenzi M, Valenti MT, Valli M, Pelilli E, Boner A, Mottes M, Antoniazzi F (2012) Lack of expression of SERPINF1, the gene coding for pigment epithelium-derived factor, causes progressively deforming osteogenesis imperfecta with normal type I collagen. J Bone Miner Res 27:723\u2013728","journal-title":"J Bone Miner Res"},{"key":"982_CR11","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1002\/stem.1505","volume":"31","author":"F Li","year":"2013","unstructured":"Li F, Song N, Tombran-Tink J, Niyibizi C (2013) Pigment epithelium-derived factor enhances differentiation and mineral deposition of human mesenchymal stem cells. Stem Cells 31:2714\u20132723","journal-title":"Stem Cells"},{"key":"982_CR12","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1096\/fj.13-232900","volume":"27","author":"AK Gattu","year":"2013","unstructured":"Gattu AK, Swenson ES, Iwakiri Y, Samuel VT, Troiano N, Berry R, Church CD, Rodeheffer MS, Carpenter TO, Chung C (2013) Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral content. FASEB J 27:4384\u20134394","journal-title":"FASEB J"},{"key":"982_CR13","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1096\/fj.201500027R","volume":"30","author":"GS Belinsky","year":"2016","unstructured":"Belinsky GS, Sreekumar B, Andrejecsk JW, Saltzman WM, Gong J, Herzog RI, Lin S, Horsley V, Carpenter TO, Chung C (2016) Pigment epithelium-derived factor restoration increases bone mass and improves bone plasticity in a model of osteogenesis imperfecta type VI via Wnt3a blockade. FASEB J 30:2837\u20132848","journal-title":"FASEB J"},{"key":"982_CR14","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1006\/bbrc.1999.1582","volume":"264","author":"H Sekiya","year":"1999","unstructured":"Sekiya H, Mikuni-Takagaki Y, Kondoh T, Seto K (1999) Synergistic effect of PTH on the mechanical responses of human alveolar osteocytes. Biochem Biophys Res Commun 264:719\u2013723","journal-title":"Biochem Biophys Res Commun"},{"key":"982_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00441-005-0066-3","volume":"323","author":"G Gu","year":"2006","unstructured":"Gu G, Nars M, Hentunen TA, Metsikko K, Vaananen HK (2006) Isolated primary osteocytes express functional gap junctions in vitro. Cell Tissue Res 323:263\u2013271","journal-title":"Cell Tissue Res"},{"key":"982_CR16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2144\/0000113876","volume":"52","author":"AR Stern","year":"2012","unstructured":"Stern AR, Stern MM, Van Dyke ME, Jahn K, Prideaux M, Bonewald LF (2012) Isolation and culture of primary osteocytes from the long bones of skeletally mature and aged mice. Biotechniques 52:361\u2013373","journal-title":"Biotechniques"},{"key":"982_CR17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1302\/2046-3758.512.BJR-2016-0102.R2","volume":"5","author":"AA Abubakar","year":"2016","unstructured":"Abubakar AA, Noordin MM, Azmi TI, Kaka U, Loqman MY (2016) The use of rats and mice as animal models in ex vivo bone growth and development studies. Bone Joint Res 5:610\u2013618","journal-title":"Bone Joint Res"},{"key":"982_CR18","doi-asserted-by":"publisher","first-page":"e78306","DOI":"10.1371\/journal.pone.0078306","volume":"8","author":"N Okubo","year":"2013","unstructured":"Okubo N, Minami Y, Fujiwara H, Umemura Y, Tsuchiya Y, Shirai T, Oda R, Inokawa H, Kubo T, Yagita K (2013) Prolonged bioluminescence monitoring in mouse ex vivo bone culture revealed persistent circadian rhythms in articular cartilages and growth plates. PLoS One 8:e78306","journal-title":"PLoS One"},{"key":"982_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s12195-009-0075-5","volume":"2","author":"ME Chan","year":"2009","unstructured":"Chan ME, Lu XL, Huo B, Baik AD, Chiang V, Guldberg RE, Lu HH, Guo XE (2009) A trabecular bone explant model of osteocyte-osteoblast co-culture for bone mechanobiology. Cell Mol Bioeng 2:405\u2013415","journal-title":"Cell Mol Bioeng"},{"key":"982_CR20","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/bonekey.2016.49","volume":"5","author":"S Marino","year":"2016","unstructured":"Marino S, Staines KA, Brown G, Howard-Jones RA, Adamczyk M (2016) Models of ex vivo explant cultures: applications in bone research. BoneKEy Rep 5:818","journal-title":"BoneKEy Rep"},{"key":"982_CR21","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1016\/j.bbadis.2018.07.034","volume":"1864","author":"F Li","year":"2018","unstructured":"Li F, Cain J, Tombran-Tink J, Niyibizi C (2018) Pigment epithelium derived factor regulates human Sost\/Sclerostin and other osteocyte gene expression via the receptor and induction of Erk\/Gsk-3beta\/beta-catenin signaling. Biochem Biophy Acta Mol Basis Dis 1864:3449\u20133458","journal-title":"Biochem Biophy Acta Mol Basis Dis"},{"key":"982_CR22","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/jbmr.345","volume":"26","author":"GJ Atkins","year":"2011","unstructured":"Atkins GJ, Rowe PS, Lim HP, Welldon KJ, Ormsby R, Wijenayaka AR, Zelenchuk L, Evdokiou A, Findlay DM (2011) Sclerostin is a locally acting regulator of late-osteoblast\/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism. J Bone Miner Res 26:1425\u20131436","journal-title":"J Bone Miner Res"},{"key":"982_CR23","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","volume":"22","author":"DG Winkler","year":"2003","unstructured":"Winkler DG, Sutherland MK, Geoghegan JC, Yu C, Hayes T, Skonier JE, Shpektor D, Jonas M, Kovacevich BR, Staehling-Hampton K, Appleby M, Brunkow ME, Latham JA (2003) Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 22:6267\u20136276","journal-title":"EMBO J"},{"key":"982_CR24","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1002\/jbmr.161","volume":"25","author":"C Paszty","year":"2010","unstructured":"Paszty C, Turner CH, Robinson MK (2010) Sclerostin: a gem from the genome leads to bone-building antibodies. J Bone Miner Res 25:1897\u20131904","journal-title":"J Bone Miner Res"},{"key":"982_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bone.2010.09.009","volume":"48","author":"X Tian","year":"2011","unstructured":"Tian X, Jee WS, Li X, Paszty C, Ke HZ (2011) Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model. Bone 48:197\u2013201","journal-title":"Bone"},{"key":"982_CR26","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1359\/jbmr.090411","volume":"24","author":"C Lin","year":"2009","unstructured":"Lin C, Jiang X, Dai Z, Guo X, Weng T, Wang J, Li Y, Feng G, Gao X, He L (2009) Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt\/beta-catenin signaling. J Bone Miner Res 24:1651\u20131661","journal-title":"J Bone Miner Res"},{"key":"982_CR27","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1359\/jbmr.080601","volume":"23","author":"WN Addison","year":"2008","unstructured":"Addison WN, Nakano Y, Loisel T, Crine P, McKee MD (2008) MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM. J Bone Miner Res 23:1638\u20131649","journal-title":"J Bone Miner Res"},{"key":"982_CR28","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1210\/en.2007-1205","volume":"149","author":"A Martin","year":"2008","unstructured":"Martin A, David V, Laurence JS, Schwarz PM, Lafer EM, Hedge AM, Rowe PS (2008) Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP. Endocrinology 149:1757\u20131772","journal-title":"Endocrinology"},{"key":"982_CR29","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1210\/en.2009-0216","volume":"150","author":"V David","year":"2009","unstructured":"David V, Martin A, Hedge AM, Rowe PS (2009) Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator. Endocrinology 150:4012\u20134023","journal-title":"Endocrinology"},{"key":"982_CR30","doi-asserted-by":"crossref","first-page":"e003179","DOI":"10.1161\/JAHA.115.003179","volume":"5","author":"P Lu","year":"2016","unstructured":"Lu P, Zhang YQ, Zhang H, Li YF, Wang XY, Xu H, Liu ZW, Li L, Dong HY, Zhang ZM (2016) Pigment epithelium-derived factor (PEDF) improves ischemic cardiac functional reserve through decreasing hypoxic cardiomyocyte contractility through PEDF receptor (PEDF-R). J Am Heart Assoc 5:e003179","journal-title":"J Am Heart Assoc"},{"key":"982_CR31","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1074\/jbc.M203250200","volume":"278","author":"LC Gowen","year":"2003","unstructured":"Gowen LC, Petersen DN, Mansolf AL, Qi H, Stock JL, Tkalcevic GT, Simmons HA, Crawford DT, Chidsey-Frink KL, Ke HZ, McNeish JD, Brown TA (2003) Targeted disruption of the osteoblast\/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem 278:1998\u20132007","journal-title":"J Biol Chem"},{"key":"982_CR32","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-13-0276","volume":"219","author":"KA Staines","year":"2013","unstructured":"Staines KA, Pollard AS, McGonnell IM, Farquharson C, Pitsillides AA (2013) Cartilage to bone transitions in health and disease. J Endocrinol 219:R1\u2013R12","journal-title":"J Endocrinol"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-018-0982-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-018-0982-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-018-0982-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T16:55:14Z","timestamp":1662742514000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-018-0982-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,3]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["982"],"URL":"https:\/\/doi.org\/10.1007\/s00774-018-0982-4","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,3]]},"assertion":[{"value":"3 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}